JAK2 and neoplasm: In a study by Wu et al., CUR significantly inhibited the activity of the JAK2/STAT3 signaling pathway in NCI‐H460 tumor spheroids, resulting in downregulation of p‐JAK2 and p‐STAT3 in a time‐ and dose‐dependent manner.